1Kligman I, Rosenwaks Z. Differentiating clinical profiles: predicting good responders, poor responders and hyperresponders. Fertil Steril,2001, 76(6): 1185-1190.
2Creus M, Penarrubia J, Fabregues F, et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod, 2000, 15(1): 2341-2346.
3Lass A. The fertility potential of women with single ovary. Hum Reprod Update, 1999, 5(5): 546-550.
4Becker NG, Macklon NS, Ei jkemans M J, et al. Women with regular menstrual cycles and a poor response to ovarian hypeistimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril, 2002, 78(2): 291-297.
5Eldar-Geva T, Margalioth EJ, Ben-Chetrit A, et al. Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders. Hum Reprod, 2002, 17(9): 2331-2337.
6Fawzy M, Lambert A, Harrison RF, et al. Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome. Hum Reprod,2002, 17(6): 1535-1543.
7Seifer DB, Scott RT Jr, Bergh PA, et al. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil Steril,1999, 72(1): 63-65.
8Bukman A, Heineman MJ. Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update, 2001, 7(6): 581-590.
9Watt AH, Legedza AT, Ginsburg ES, et al. The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization. J Assist Reprod Genet,2000. 17(5): 264-268.
10Fabregues F, Balasch J, Creus M, et al. Ovarian reserve test with human menopausal gondotropin as a predictor of in vitro fertilization outcome. J Assist Reprod Genet, 2000, 17(1): 13-19.
